Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Eli Lilly

Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review

Small caps and much of the market soared on tame CPI inflation data, while the extended Nasdaq sold off.

Investors Business Daily

Tesla And Nvidia Investors Dangerously Delude Themselves

Stock prices anticipate the future. But such wishful thinking is reaching some extreme levels in the S&P 500.

Investors Business Daily

These weight-loss startups tell customers they can stop taking Ozempic or Wegovy and stay thin. Doctors disagree

As nearly $1 billion of venture capital dollars have been injected into weight-loss startups since 2023, companies are making unproven claims to attract customers. It’s a new twist on a story as old as the diet industry.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic

Patients lost more significantly more weight on Eli Lilly's Mounjaro than Novo Nordisk's Ozempic, according to a new study.

Investors Business Daily

Eli Lilly Weight Loss Drug Beats Ozempic In Head-to-head Study

Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk's Ozempic, a head-to-head study published Monday showed.

International Business Times

Stocks Close Mixed As Nasdaq, S&P 500 Keep Trend Alive; Dow Falters (Live Coverage)

The Dow Jones eased while the S&P 500 and Nasdaq held a small gain on the stock market today. The small-caps Russell 2000 outpaced the major indexes.

Investors Business Daily

Eli Lilly Snaps Up Morphic For $3.2 Billion; Morphic Stock Hits The Stratosphere

Eli Lilly said Monday it would acquire Morphic Holding for $3.2 billion, and Morphic stock skyrocketed to a 10-month high.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

The Next $1 Trillion Stock? AI Play Briefly Joins Club; Tesla, Warren Buffett's Berkshire Hathaway Close

Which will be the next $1 trillion stock? Taiwan Semiconductor briefly joined the club Monday. Tesla and Warren Buffett's Berkshire are getting closer.

Investors Business Daily

Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review

Tesla drove the S&P 500 and Nasdaq to highs, though small caps fell for the week. Cooling economic data raised rate-cut hopes.

Investors Business Daily

Best Mutual Fund Hits Home Runs In Addition To Nvidia

Delaware Ivy Global Growth Fund isn't about betting on one country. It's not about going all-in on a trend like AI for the best mutual fund.

Investors Business Daily

Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers

Remarks came after the president and Senator Bernie Sanders blasted the pharmaceutical giant for its ‘unconscionably high prices’

The Independent UK

Novo, Lilly Tumble After Study Ties Blindness Disorder To Weight-Loss Drugs

Novo Nordisk stock skidded Wednesday after a new study suggests its diabetes and weight-loss drug can lead to a blindness-causing disease.

Investors Business Daily

Microsoft Snags One Crown, Snatches Another From Nvidia

Microsoft stock topples Nvidia on the latest list of new buys by top funds as 13 names make the billion-dollar club.

Investors Business Daily

What Is Kisunla? Know All About New FDA-Approved Drug For Alzheimer's Disease

Kisunla manufactured by Eli Lilly could significantly slow cognitive decline in people with early symptomatic Alzheimer's disease, according to results of the company's clinical trials.

Medical Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

FDA Approves New Alzheimer's Drug To Slow Disease Progression

FDA approves Eli Lilly's donanemab for early Alzheimer's, offering hope for patients and caregivers. Treatment priced at 5 per vial.

The Guardian - US

FDA approves second Alzheimer’s drug that can slow onset of disease

Eli Lilly says Kisunla demonstrated ‘meaningful results’ for people showing early symptoms of the disease

Investors Business Daily

Dow Jones Jumps 162 Points As Powell Says This On Rate Cuts; Tesla Value Soars $68 Billion As Deliveries Crush Views

The Dow Jones rose after Fed Chair Jerome Powell spoke out on inflation. Tesla surged on deliveries. President Biden hit out at some firms.

Investors Business Daily

Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug

Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.

International Business Times

Biden Calls For Lower Prices Of Ozempic, Similar Drugs

US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."

Investors Business Daily

Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1

Nvidia has more than doubled so far this year, but the biggest S&P 500 stock winner is Super Micro, one of several big AI performers.

Barchart

3 Mega-Cap Stocks to Consider Before They're Worth $1 Trillion

Mega-cap stocks are the flavor of the season, and these three big names are the next set of contenders racing towards the $1 trillion market cap club.

Investors Business Daily

Eli Lilly Option Trade Could Make $4,000 With A Pullback

This broken wing butterfly trade has a profit zone between 810 and 890.

Barchart

Chart of the Day: Eli Lilly - More New Highs

Author's Note: Last featured 10/26/23 at $586.37. Gained 54% since that date. The Chart of the Day belongs to the drug manufacturer Eli Lilly (LLY) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current...

Fortune

Novo Nordisk’s Wegovy may just have two years to take over China’s market for weight loss drugs

Novo Nordisk's China patent on Wegovy's active ingredient expires in 2026, much earlier than its patents in the U.S., Japan and Europe.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations